Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
23.16
-0.01 (-0.04%)
Aug 22, 2025, 3:04 PM CST
SHE:300122 Revenue
Chongqing Zhifei Biological Products had revenue of 2.54B CNY in the quarter ending June 30, 2025, a decrease of -62.92%. This brings the company's revenue in the last twelve months to 12.73B, down -72.76% year-over-year. In the year 2024, Chongqing Zhifei Biological Products had annual revenue of 26.07B, down -50.74%.
Revenue (ttm)
12.73B
Revenue Growth
-72.76%
P/S Ratio
4.35
Revenue / Employee
1.76M
Employees
7,220
Market Cap
55.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.07B | -26.85B | -50.74% |
Dec 31, 2023 | 52.92B | 14.65B | 38.30% |
Jan 1, 2023 | 38.26B | 7.61B | 24.83% |
Dec 31, 2021 | 30.65B | 15.46B | 101.79% |
Dec 31, 2020 | 15.19B | 4.60B | 43.48% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.90B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |